Zelira Therapeutics Limited

ASX:ZLD Stock Report

Market Cap: AU$7.3m

Zelira Therapeutics Limited Company Information

Zelira Therapeutics Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Zelira Therapeutics Limited
  • Ticker: ZLD
  • Exchange: ASX
  • Founded: 2003
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: AU$7.262m
  • Shares Outstanding: 11.35m
  • Website: https://zeliratx.com

Location

  • Zelira Therapeutics Limited
  • 101 St Georges Terrace
  • Level 3
  • Perth
  • Western Australia
  • 6000
  • Australia


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ZLDASX (Australian Securities Exchange)YesOrdinary SharesAUAUDNov 2016
G1GDB (Deutsche Boerse AG)YesOrdinary SharesDEEURNov 2016
ZLDCHIA (Chi-X Australia)YesOrdinary SharesAUAUDNov 2016
ZLDA.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDNov 2016

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/23 04:57
End of Day Share Price 2024/11/22 00:00
Earnings2024/06/30
Annual Earnings2024/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.